United States Hospital-acquired Infections Prevention Market Report, 2010-2020

1
Un i ted S tates Ho s pi tal - acqui red In fec
t i o n s Preven t i on Market Opportun i t i
es, 2010 - 20 2 0
P h a r m a H e a l t h c a r e C o n
s u l t a n t s
2
R e s e a r c h M e t h o d o l o g y
US Hospital-acquired Infections Prevention
Market Opportunities, 2020
Secondary Research
Primary Research
Identifying Key Opinion Leaders Questionnaire
Design In-depth Interviews Coverage across
Value Chain market
Government websites Company annual reports,
white papers, investor presentations and
financial reports
Preliminary Data Mining
Qualitative and Quantitative research
Data Validation, Analysis and Interpretation
Data validation through Primary Secondary
outreach, data analysis and interpretation of
key findings
Market Estimation Forecasting ?Bottom-Up or
Top-down approach for Market size
estimation ?Historical trend examination ?Impact
analysis of drivers and challenges to market
growth ?Statistical evaluation to develop the
actual forecast CAGR (2015E-2020F) XX 2
2015E 2016F 2017F 2018F 2019F 2020F
3
R e s e a r c h M e t h o d o l o g y
Baseline Methodology For the study of the United
States hospital-acquired infections prevention
market, Pharmaion has gathered information
through an exhaustive search of credible
databases prudently evaluated all the collected
information and presented it in the most
accurate and detailed manner.
Primary Sources
Qualitative and quantitative data from company
website, financial reports, research articles,
designed questionnaires etc.

• Key Stakeholders
• Product/Brand Managers
• Business Development
• Managers
• Regional Mangers
• Regulatory Affairs Personnel
• Marketing Sales Managers
• Head of Patient Support Programme

In-depth interviews of key stakeholders of
major companies
Data Triangulation (Data validation through
cross verification from primary secondary
sources)
Secondary Sources

• Analysis of Data from credible sources
• Centers for Disease Control and Prevention (CDC)
• American Cancer Institute
• American Hospital Directory

Substantial data points for analysis,
interpretation and market size estimation
3
4
R e s e a r c h M e t h o d o l o g y

• United States Hospital-acquired Infections
  Prevention Market - Market Size Estimation
• United States Hospital-acquired Infections
  Prevention market has been segmented into two
  categories Disinfection and Sterilization
• Sterilization has been further categorized into
  three sub-segments Equipment, Services, and
  Consumables
• Disinfection has been further classified into six
  sub segments Disinfection Robots, Disinfectants,
  Endoscope Reprocessors, Disinfectors, Wipes, and
  Personal-use Non-wovens.

Total Market Size Sterilization Market Size
Disinfection Market Size
Calculation of United States Sterilization for
Hospital-acquired Infections Prevention Market
Size
Calculation of United States Disinfection for
Hospital- acquired Infections Prevention
Market Size
Top-down Approach
Bottom-up Approach
Calculation of Sub- segment market size
Regional Company Market Size Respective
Market Share (from primary and secondary
research) X Total Market Value
Calculation of Sub- segment market size
4
5
T a b l e o f C o n t e n t s
S No. Contents Contents Contents
1. Hospital-acquired Infections Prevention Overview Hospital-acquired Infections Prevention Overview Hospital-acquired Infections Prevention Overview
2. Research Methodology Research Methodology Research Methodology
3. Analyst View Analyst View Analyst View
4. Global Hospital-acquired Infections Prevention Market Overview Global Hospital-acquired Infections Prevention Market Overview Global Hospital-acquired Infections Prevention Market Overview
5. United States Hospital-acquired Infections Prevention Market Outlook United States Hospital-acquired Infections Prevention Market Outlook United States Hospital-acquired Infections Prevention Market Outlook
5.1. Market Size and Forecast Market Size and Forecast
5.1.1. By Value
5.2. Market Share Forecast Market Share Forecast
5.2.1. By Prevention Type
5.2.2. By Region
5.2.3. By Company
6. United States Sterilization for Hospital-acquired Infections Prevention Market Outlook United States Sterilization for Hospital-acquired Infections Prevention Market Outlook United States Sterilization for Hospital-acquired Infections Prevention Market Outlook
6.1. Market Size and Forecast Market Size and Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Type
7. United States Disinfection for Hospital-acquired Infections Prevention Market Outlook United States Disinfection for Hospital-acquired Infections Prevention Market Outlook United States Disinfection for Hospital-acquired Infections Prevention Market Outlook
7.1. Market Size and Forecast Market Size and Forecast
7.1.1. By Value
7.2. Market Share Forecast Market Share Forecast
7.2.1. By Type
5
6
T a b l e o f C o n t e n t s
S No. Contents Contents Contents
8. Market Dynamics Market Dynamics Market Dynamics
8.1. Drivers Drivers
8.2. Challenges Challenges
9. Market Trends Developments Market Trends Developments Market Trends Developments
9.1. UV Disinfecting Robots Future of Disinfection UV Disinfecting Robots Future of Disinfection
9.2. Plummeting Surgical Site Infections Plummeting Surgical Site Infections
9.3. RFID Technology for Monitoring Hand Hygiene RFID Technology for Monitoring Hand Hygiene
9.4. Gas Plasma Sterilization Technology Gas Plasma Sterilization Technology
9.5. Hospital Infection Prevention from Digital Technology Hospital Infection Prevention from Digital Technology
10. Regulatory Framework and Guidelines Regulatory Framework and Guidelines Regulatory Framework and Guidelines
10.1. Deficit Reduction Act of 2005 Deficit Reduction Act of 2005
10.2. Guidelines Guidelines
11. United States Economic Profile United States Economic Profile United States Economic Profile
12. Competitive Landscape Competitive Landscape Competitive Landscape
12.1. Competition Benchmarking Competition Benchmarking
12.2. Company Profiles Company Profiles
12.2.1. Steris Corporation
12.2.2. Advanced Sterilization Products
12.2.3. Getinge USA, Inc.
12.2.4. 3M Company
12.2.5. Belimed
12.2.6. Cantel Medical Corp.
6
7
T a b l e o f C o n t e n t s
S No. Contents Contents Contents
12.2.7. Halyard Health, Inc.
12.2.8. Cisa America Inc.
12.2.9. Cardinal Health, Inc.
12.2.10. Tuttnauer USA Co. Ltd.
13. Strategic Recommendations Strategic Recommendations Strategic Recommendations
14. About Us Disclaimer About Us Disclaimer About Us Disclaimer
7
8
I n d u s t r y B r i e f United States
Hospital-acquired Infections Prevention Market to
Grow at Over 7 Until 2020 Growing incidence of
hospital-acquired infections and stringent
government policies to drive the United
States hospital-acquired infections prevention
market through 2020 According to recently
published Pharmaion report,United States
Hospital-acquired Infections Prevention Market
Opportunities, 2010 - 2020, hospital-acquired
infections prevention market in the United States
is projected to grow at a CAGR of over 7 during
2015 - 2020. Growth in the US hospital-acquired
infections prevention market can be attributed
to growing incidence of hospital-acquired
infections and rising prevalence of chronic
diseases among geriatric population. Moreover,
implementation of stringent laws against
hospitals with regards to hospital- acquired
infections, under the Deficit Regulation Act,
2005,is also anticipated to drive demand for
hospital- acquired infections prevention market
in the United States during 2015 - 2020. On the
basis of prevention type, the market has been
segmented into two categories, namely,
sterilization and disinfection. Among these
categories, sterilization segment dominated the
United States hospital-acquired infections
prevention market in 2014, and is anticipated to
continue its dominance during forecast period on
account of its high efficiency and capability to
clean and kill microorganisms in extreme corners
of medical devices used in diagnostic and
treatment procedures. South region accounted for
the largest share in the United States
hospital-acquired infections prevention market in
2014, followed by the Midwest, West and
North-East regions.
With increasing adoption of UV disinfecting
robots and RFID, a technology for monitoring hand
hygiene, coupled with growing adoption of gas
plasma sterilization technology, the market for
hospital-acquired infections prevention market
in the United States is anticipated to grow at a
robust pace over the next five years. Moreover,
Office of Disease Prevention and Health Promotion
(ODPHP) and US Department of Health and Human
Services (HHS) developed the National Action
Plan to Prevent Health Care-Associated
Infections Road Map to Elimination in 2009.
This plan was focused to prevent
hospital-acquired infections across all health
care settings, including acute care hospitals,
ambulatory surgical centres, end-stage renal
disease facilities and long-term care
facilities. said Mr. Karan Chechi, Research
Director, with Pharmaion Consultants, a research
based global pharmaceutical and healthcare
consulting firm.
8
Pharmaion
9
H o s p i t a l - a c q u i r e d I n f e c t i
o n s P r e v e n t i o n O v e r v i e w
Hospital-acquired Infections
Hospital-acquired infection, also known as
nosocomial infection, is defined as an infection
whose development takes place in a favourable
hospital environment, specifically those which
are acquired by a patient during a hospital
visit and often develop among the hospital
staff. Hospital-acquired infections majorly leads
to severe pneumonia and infections of
bloodstream, urinary tract and other parts of
the body. United States Hospital-acquired
Infections Share, 2013 Abbreviations Used
VAP, 20
XXXX
SSI, 20
XXXX XXXX CLABSI, 20 XXXX CAUTI,
20 XXXX HO-HCFA CDI, 20 9
10
S a m p l e D a t a - S n a p s h o t
United States Hospital-acquired Infections
Prevention Market Size, By Region, By Value,
2010-2014 (USD Million)
North-East Region
Midwest Region
5
4
5
3
4
2
3
1
2
1
2010 2011 2012 2013 2014
2010
2011 2012 2013
2014
United States Costs of Commonly Hospital-acquired
Infections Diagnosis Treatment, 2012 ()
West Region
5
4
Catheter- associated UTIs, 20.0
3
Surgical Site Infections, 20.0
2
South Region
1
5
4
3
2010 2011 2012
2013
2014
C. Difficile Infections, 20.0
2
1
Ventilator- associated Pneumonia, 20.0
Central line- associated bloodstream infection,
20.0
United States Number of Deaths from 10 Leading
Causes, 2013
2010 2011 2012 2013 2014
10
9
United States Hospital-acquired Infections
Prevention Market Share, By Company, By Value,
2010-2020F
8
7
6
5
4
3
2
1
31 31.1 31.2 31.3 31.4 31.5 31.6 31.7 31.8 31.9 32
16 16.1 16.2 16.3 16.4 16.5 16.6 16.7 16.8 16.9 17
14 14.1 14.2 14.3 14.4 14.5 14.6 14.7 14.8 14.9 15
5 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 6

30.1 30.2 30.3 30.4 30.5 30.6 30.7 30.8 30.9 31 31.1
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
United States Hospital-acquired Infections
Prevention Market Size, By Value, 2010-2020F (USD
Billion)
11
10
9
8
7
6
5
4
3
2
1
10
Others
3M Company
Getinge USA Inc.
ASP
Steris Corporation
11
Report Name United States Hospital-acquired
Infections Prevention Market Opportunities,
2010-2020
R e p o r t O r d e r i n g
Report Price
License Type Price
Single User License 2500
Single User License Print 3000
Enterprise License 5000
To View Sample OR Purchase Report
11
12
A b o u t U s D i s c l a i m e r
About Us Pharmaion is a research based
management consulting firm focused exclusively on
Healthcare Pharmaceutical industry. Pharmaion
s core values are value, integrity and insight.
Led by a team of dynamic industry experts,
Pharmaion provides its customers with high value
market research and advisory services that helps
them identify new market opportunities, growth
engines and innovative ways to capture the
market share. As a result, Pharmaions clients
lead rather than follow market trends. Not bound
by legacy, Pharmaions cutting-edge research
model leverages its decades of research knowledge
and an increased use of technology as engines of
innovation to deliver unique research value.
Provided as an alternative to traditional market
research, Pharmaions reports do not just
deliver data and knowledge rather highlights the
insights in a more usable and interactive format
for its clients. Pharmaion is committed to
assisting customers worldwide with their unique
market research needs by providing them with
comprehensive, value-added solutions and
professional market intelligence services.
Pharmaion employs the industrys best-trained
industry Analysts and Consultants, which advises
and assists customers in meeting their full
service market research and consulting
requirements. Related Reports United States
Autoimmune Disorders Diagnostics Market
Opportunities, 2020 Global Tissue Engineered
Medical Devices Market Opportunities, 2020 Global
Cervical Cancer Vaccine Market Opportunities,
2020 Disclaimer The contents of this report
are based on information generally available to
the public from sources believed to be reliable.
No representation is made that it is timely,
accurate or complete. Pharmaion Consultants has
taken due care and caution in compilation of data
as this has been obtained from various sources
including which it considers reliable and first
hand. However, Pharmaion Consultants does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
Pharmaion Consultants.
NORTH AMERICA Pharmaion Consultants LLC 708 3RD
Avenue, 6th Floor, New York, NY, United State,
10017 sales_at_pharmaion.com 1 646 360
1656 www.pharmaion.com
ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A
51, Sector 57, Noida, National Capital
Region, India - 201301 sales_at_pharmaion.com 91 -
120 - 452 3900 www.pharmaion.com
12